Chemotherapy and Magazine - Pharmacist Digest

The drug Fenbendazole can make tumors sensitive to radiotherapy just like agents of chemotherapy

Pharma Mirror

MARCH 8, 2021

The post The drug Fenbendazole can make tumors sensitive to radiotherapy just like agents of chemotherapy appeared first on Pharma Mirror Magazine. 2] Presumably, fenbendazole multitherapy along with this little. 2] Presumably, fenbendazole multitherapy along with this little.

Chemotherapy

DuPont Announces Research Collaboration with Rutgers University

Pharma Mirror

JULY 23, 2020

The two-year research partnership will focus on improving the benefit/risk ratio of chemotherapy by decreasing gut inflammation caused by chemotherapy to potentially improve response rates through modulation. The post DuPont Announces Research Collaboration with Rutgers University appeared first on Pharma Mirror Magazine.

Chemotherapy

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

pharmaphorum

JUNE 8, 2021

Chemotherapy still accounted for 72.6% Chemotherapy still plays a significant role in oncology treatment, accounting for 72.6% While all of the top ten best-selling oncology drugs in the US in 2019 were innovative therapies, four out of the top ten best-selling oncology drugs in China were for conventional chemotherapy. “In

Chemotherapy

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunity

Checkpoint inhibitors, Enhertu in spotlight as ASCO resumes in-person meetings

pharmaphorum

AUGUST 18, 2022

At six months, all patients had no evidence of a tumour, allowing them to skip the chemotherapy and/or surgery that would normally be their next treatment. • Read the full article in pharmaphorum’s Deep Dive digital magazine.

Chemotherapy

Chemotherapy Immunization Immunity

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Pharmaceutical Technology

JULY 1, 2025

Go deeper with GlobalData Reports Chemotherapy in Pharmaceuticals: Platinum-based cancer drug composi. Sign up Share Copy Link Share on X Share on Linkedin Share on Facebook Go deeper with GlobalData Reports Chemotherapy in Pharmaceuticals: Platinum-based cancer drug composi. Sign up for our daily news round-up!

Packaging

Packaging Drug Development Chemotherapy Biosimilars

Biocon’s Denosumab biosimilars gain EU marketing authorisation

Pharmaceutical Technology

JULY 4, 2025

Go deeper with GlobalData Reports LOA and PTSR Model - Denosumab Biosimilar in Bone Metastasis Reports LOA and PTSR Model - Denosumab Biosimilar in Chemotherapy Effects Data Insights The gold standard of business intelligence. Find out more Sign up for our daily news round-up! Give your business an edge with our leading industry insights.

FDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiency

Pharmaceutical Technology

JULY 1, 2025

In June 2025, the European Commission authorised Takeda’s Adcetris (brentuximab vedotin), an antibody-drug conjugate, combined with chemotherapy for treating adults who are newly diagnosed with Stage IIb Hodgkin’s lymphoma with risk factors or at Stage III/IV. Sign up for our daily news round-up!

Packaging

Packaging Communication Hospitals Drug Pricing

FDA approves Dizal’s Zegfrovy to treat adults with NSCLC

Pharmaceutical Technology

JULY 3, 2025

Dizal has received US Food and Drug Administration (FDA) approval for Zegfrovy (sunvozertinib) to treat adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations (exon20ins), following progression on or after receiving platinum-based chemotherapy.

Packaging

Packaging Communication Hospitals Drug Pricing

Jan van de Winkel: Building Europe’s biotech powerhouse at Genmab

pharmaphorum

APRIL 7, 2021

There’s potential for combination drugs, paving the way for less toxic chemotherapy-free cancer drugs. Richard also contributes to pharmaphorum’s digital magazine, DeepDive. Genmab’s HexElect antibodies are based on co-dependent antibodies with dual targeting plus enhanced potency and selectivity.

Chemotherapy

Chemotherapy Hospitals Vaccines

Amgen's Five Prime takeover delivers gastric cancer win

pharmaphorum

JULY 1, 2025

The new data comes from the FORTITUDE-101 looking at bemarituzumab plus chemotherapy as a front-line therapy for FGFR2b-positive advanced gastric cancer, and has revealed a significant improvement in overall survival (OS) compared to placebo plus chemo.

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Chemotherapy

J&J eyes prostate cancer label expansion for Akeega

Pharmaceutical Technology

JULY 7, 2025

Find out more J&J’s drug is an option for patients where medical or surgical treatment to lower testosterone levels has not worked, and in those who have BRCA 1/2 mutations – a subset of homologous recombination repair (HRR) mutations – in whom chemotherapy is not indicated.

Labelling

Labelling Packaging Communication Hospitals

AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer

Pharmaceutical Technology

JULY 4, 2025

Imfinzi is now approved to treat adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with chemotherapy drugs gemcitabine and cisplatin as neoadjuvant treatment, and as a monotherapy after bladder removal surgery. Imfinzi is a major revenue driver for AstraZeneca, generating around $4.7bn in sales in 2024.

Chemotherapy

Chemotherapy Packaging Labelling Communication

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

JULY 4, 2025

Go deeper with GlobalData Reports Chemotherapy in Pharmaceuticals: Platinum-based cancer drug composi. Nominate Now Share Copy Link Share on X Share on Linkedin Share on Facebook Go deeper with GlobalData Reports Chemotherapy in Pharmaceuticals: Platinum-based cancer drug composi. Find out more Sign up for our daily news round-up!

Pharmacist Digest

The drug Fenbendazole can make tumors sensitive to radiotherapy just like agents of chemotherapy

DuPont Announces Research Collaboration with Rutgers University

Trending Sources

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

Checkpoint inhibitors, Enhertu in spotlight as ASCO resumes in-person meetings

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Biocon’s Denosumab biosimilars gain EU marketing authorisation

FDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiency

FDA approves Dizal’s Zegfrovy to treat adults with NSCLC

Jan van de Winkel: Building Europe’s biotech powerhouse at Genmab

Amgen's Five Prime takeover delivers gastric cancer win

J&J eyes prostate cancer label expansion for Akeega

AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer

Big pharma braces for revenue headwinds as patent expiries loom

Stay Connected